This content is machine translated Diabetes mellitus Biomarker-associated clustering for improved treatment management. Phenotyping and subclassification of diabetic patients is becoming increasingly important to provide patient-adapted treatment options. Meanwhile, there are several cluster analyses that could reveal certain specific patterns of patient characteristics.…
View Post 4 min This content is machine translated Type 2 diabetes: Update 2021 SGLT-2 inhibitors and GLP-1-RA: added value to treatment. Early detection and follow-up are critical for the management of type 2 diabetes mellitus. This is more relevant than ever in the current COVID 19 pandemic. The goals of modern diabetes…
View Post 7 min This content is machine translated Rheumatoid arthritis Lasting remission through targeted treatment Despite great advances in the management of rheumatoid arthritis, many patients do not respond satisfactorily (or adequately) to available treatments [1]. Data from clinical trials of a targeted disease-modifying antirheumatic…
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 1: SGED Recommendations The digital and CME-certified continuing education series “Dia-Month Club” on type 2 diabetes started on April 30.Our expert, Prof. Roger Lehmann (University Hospital Zurich), explains in the first module the… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 2: (Post-)Pandemic On May 17, the second module of the Dia-Month Club on the (post)pandemic took place. Our expert, Prof. Marc Donath (University Hospital Basel), spoke on the exciting question: Does Covid-19… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 3: LDL cholesterol On June 25, the third module of the Dia-Month Club took place, focusing on an often underestimated risk factor, LDL cholesterol. Our expert, Prof. Isabella Sudano (University Hospital Zurich), presented… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 4: Heart In the fourth module of the Dia-Month Club on September 3, Prof. Christian Müller (University Hospital Basel) used current data to show how modern diabetes management decisively reduces the patient’s… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 5: Kidney On October 26, the fifth module of the Dia-Month Club was held on the topic of kidneys. Our expert, PD Dr. Michael Mayr (University Hospital Basel), explained the practical guardrails… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 6: Consequential diseases On November 18, the sixth module of the Dia-Month Club was held on the topic of secondary diseases of type 2 diabetes. Our expert, Dr. Thanh-Truc Ngô Bá (St. Claraspital,… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 7: Digital Tools On December 9, the seventh and final module of the 2021 Dia-Month Club was held on the topic of digital tools. Our expert, Prof. Roger Lehmann (University Hospital Zurich), explained… CME-Test
View Post 5 min This content is machine translated Type 2 diabetes mellitus SGLT-2 inhibitor has cardioprotective effect in different risk groups Type 2 diabetes mellitus (T2DM) significantly increases the risk of cardiovascular complications [1]. However, SGLT-2 inhibitors may prevent cardiovascular events in addition to lowering blood glucose levels [2, 3]. For…
